510(k) K810967
K810967 is an FDA 510(k) premarket notification submitted by Clinical Assays, Inc. for the device "IN-VITRO TBG RADIOIMMUNOASSAY TEST". The FDA issued a decision of Substantially Equivalent on Apr 23, 1981. The device falls under product code CEE (Radioimmunoassay, Thyroxine-Binding Globulin), a Class II device regulated under 21 CFR 862.1685. Clinical Assays, Inc. has 26 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Apr 23, 1981
- Date Received
- Apr 8, 1981
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Radioimmunoassay, Thyroxine-Binding Globulin
- Device Class
- Class II
- Regulation Number
- 862.1685
- Review Panel
- CH
- Submission Type
- 510(k) Exempt
Need the full FDA record for Clinical Assays, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.